Viagra & Melanoma

The commonly used erectile dysfunction drug Viagra has been linked to melanoma skin cancer.

Viagra is the brand name version of the drug sildenafil, sold by British pharmaceutical giant Pfizer. It was the first oral medication ever introduced for male erectile dysfunction, and is still the most popular on the market.

viagra lawsuit

About Viagra

The widely used erectile dysfunction drug Viagra has been linked to severe health risks, including skin cancer.

Originally approved by the FDA only for erectile dysfunction, Viagra has since also been authorized to treat a rare lung condition called pulmonary arterial hypertension.            

Viagra was first discovered while scientists searched for a new treatment for hypertension and heart disease. Instead, they found the compound sildenafil could treat erectile dysfunction by restricting the enzyme PDE5, which limits blood flow to the penis.            

Since 1998, Viagra has been used by an estimated 23 million men around the world. Even with the launch of competitors Cialis and Levitra, it still accounts for more than half of all ED medication sales.            

It is available in dosages of 25, 50 and 100 mg tablets.            

Unfortunately, new reports suggest Viagra may have serious health risks. A recent study showed those who have taken it have a higher chance of developing skin cancer.            

Anyone who has used Viagra or is currently taking it is urged to talk with their doctor about the risks. Those diagnosed with skin cancer may also be entitled to compensation, as lawyers are investigating lawsuits against Pfizer.

Viagra Skin Cancer

In April 2014, the Journal of the AMA published a study from researchers at Harvard University, Brown University and Brigham and Womens Hospital that followed nearly 26,000 men around the age of 65. It found those who had used Viagra in the past had a 92% increased chance of developing skin cancer, while recent users had an 84% higher occurrence rate.

Viagra Link to Skin Cancer

Interestingly, the Viagra skin cancer link was present in men regardless of whether they had a family history of skin cancer, increased exposure to ultraviolet light where they lived, or had been diagnosed with other kinds of cancer and major illnesses in the past.            

Since the study was only based on a blind survey, researchers are careful to say they have not determined what component of Viagra may cause skin cancer. However, the chair of the study commented that the drug could alter the genetic pathway that guards the body from aggressive skin cancer growths like melanoma.            

Researchers also caution that more testing is necessary to determine the true risk of Viagra skin cancer. For now, though, the connection is troubling due to the massive popularity of the drug and the serious risks of the disease.

Side Effects

Early trials revealed several common side effects of Viagra, including:

  • Headaches
  • Flushing
  • Heart attack
  • Nasal congestion
  • Indigestion
  • Stroke
  • Painful lasting erections
  • Low blood sugar
  • Eye pressure.

Additional post-marketing studies showed Viagra side effects may also be linked to vision problems and hearing loss. Now, a recent study published by the American Medical Association suggests the skin cancer melanoma may also be among the dangerous side effects of Viagra.

Free Case Review

Viagra Lawsuits

Due to the failure of Pfizer to warn of the potential risks for skin cancer from Viagra, they may be liable to those affected.

Lawyers are currently investigating claims against Pfizer for patients who developed melanoma, and are available to discuss your case today. It costs nothing for a consultation or to file a claim.

For more information on the research, side effects or skin cancer risks associated with Viagra, or to speak with a lawyer, contact us today.

Sources of information

Get in touch with us.

Call, email or live chat with us today to see how we can help.

call DrugNews.net
Need a quick answer? Call us!
email DrugNews.net
Reach out to us by email.
live chat with DrugNews
We are here to help now